Invention Grant
- Patent Title: Cyclosporin analogues for preventing or treating hepatitis C infection
-
Application No.: US14931384Application Date: 2015-11-03
-
Publication No.: US09669095B2Publication Date: 2017-06-06
- Inventor: Guoqiang Wang , In Jong Kim , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee: ENANTA PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: A61K38/13
- IPC: A61K38/13 ; C07K7/64 ; A61K45/06 ; A61K38/21 ; A61K31/7056
Abstract:
The present invention relates to novel cyclosporine analogs having antiviral activity against HCV and useful in the treatment of HCV infections. More particularly, the invention relates to novel cyclosporine analog compounds, compositions containing such compounds and methods for using the same, as well as processes for making such compounds.
Public/Granted literature
- US20160130304A1 NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION Public/Granted day:2016-05-12
Information query
IPC分类:
